Open main menu

Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA) (Q61967478)

clinical trial
edit
Language Label Description Also known as
English
Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)
clinical trial

    Statements

    SABA (English)
    0 references
    0 references
    Safety, Tolerability And Mechanism Of Action Of Boswellic Acids In Multiple Sclerosis and Clinically Isolated Syndrome: A MRI-Controlled, Multicenter, Baseline-To-Treatment, 32-Weeks, Open-Label, Phase IIa Trial (English)
    0 references
    0 references
    0 references
    September 2011
    0 references
    December 2014
    0 references
    29
    0 references
    18 year
    0 references
    65 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit